Zurich, Switzerland

Christoph Dumelin

USPTO Granted Patents = 1 

 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:

goldMedal1 out of 832,891 
Other
 patents

Years Active: 2018

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christoph Dumelin: Pioneering Solutions through Innovative Research

Introduction

Christoph Dumelin, a distinguished inventor based in Zurich, Switzerland, has made significant contributions to the field of medical research. With one patent to his name, Dumelin has focused on developing innovative compounds that can address various health issues.

Latest Patents

Dumelin's notable patent revolves around "Soluble epoxide hydrolase inhibitors and uses thereof." This invention highlights compounds that possess soluble epoxide hydrolase inhibitory activity. The therapeutic potential of these compounds extends to treating or preventing an array of medical conditions, including cardiovascular diseases, respiratory ailments, inflammation, and diabetes. The work exemplifies Dumelin's commitment to advancing medical science through innovative solutions.

Career Highlights

Throughout his career, Christoph Dumelin has been dedicated to research and innovation, making strides that contribute to healthcare advancements. His work is characterized by a focused approach on developing compounds that could change treatment paradigms for various diseases.

Collaborations

Dumelin has collaborated with colleagues such as Ying Victor Zhang and Anthony Dominic Keefe. These partnerships often enhance the depth of research and broaden the impact of their innovative discoveries in the medical field.

Conclusion

In summary, Christoph Dumelin stands out as an inventive force in Zurich's research landscape. His patented work on soluble epoxide hydrolase inhibitors not only showcases his innovative spirit but also offers promising solutions for critical medical challenges. As he continues to collaborate and push the boundaries of scientific research, Dumelin's contributions may well pave the way for new treatment possibilities.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…